Νοέ32015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα3 Νοεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.ΕπόμενοNext post:Σύνοψη AASLD 2015Σχετικά ΆρθραEstablishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma19 Ιανουαρίου 2026The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis14 Ιανουαρίου 2026The burden of extrahepatic organ failures in European patients with cirrhosis15 Δεκεμβρίου 2025Linerixibat in patients with primary biliary cholangitisand cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial28 Νοεμβρίου 2025Sex and body size disparities under MELD 3.0: Evaluation of persisting gaps in liver transplant access16 Νοεμβρίου 2025Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C6 Νοεμβρίου 2025
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma19 Ιανουαρίου 2026
The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis14 Ιανουαρίου 2026
Linerixibat in patients with primary biliary cholangitisand cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial28 Νοεμβρίου 2025
Sex and body size disparities under MELD 3.0: Evaluation of persisting gaps in liver transplant access16 Νοεμβρίου 2025
Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C6 Νοεμβρίου 2025
